1Kass E, Parker J, Schlom, et al . Comparative studies of the effects of recombiant GM-CSF and GM-CSF administered via a poxvirus to enhance the concentration of antigen presenting cells in regional lymphnodes[J]. Cytokine ,2000,12(7) :960
2Dinc S,Gulcelik MA,Kuru B, et al .Effects of locally applied recombinant human granulocyte-macrophage colony-stimulating factor on ischemic bowel anastomoses in rat[J]. Eur Surg Res ,2004,36(1):59
3Asahara T, Masuda H. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization[J]. Circ Res, 1999,85: 221
5Kalka C,Masuda H,Takahashi T, et al .Transplantation of exvivo expanded endothelial progenitor cells for therapeutic neovascularization[J]. Proc Natl Acad Sci USA ,2000,97:3422
6Wu FP, Westphal JR, Hoekman K, et al . The effects of surgery, with or without rhGM-CSF, on the angiogenic profile of patients treated for colorectal carcinoma[J]. Cytokine ,2004,25(2):68
7Wagner W,Alfrink M,Haus U, et al .Treatment of irradiation-induced mucositis with growth factors (rhGM-CSF) in patients with head and neck cancer[J]. Anticancer Res, 1999,19 (1B):799
8Nicolatou O, Sotiropoulou LA, Skarlatos J. A pilot study of the effect of granulocyte-macrophage colony-stimulating factor on oral mucositis in head and neck cancer patients during X radiation therapy:A preliminary report[J], Int J Radiat Oncol Biol Phys ,1998,42(3):5516
9Koukourakis MI, Flordellis CS, Giatromanolaki A, et al . Oral administration of recombinant human granulocyte-macrophage colony-stimulating factor in the management of radiotherapy induced esophagitis[J]. Clin Cancer Res , 1999,5(12):3970
10Koc M, Onuk MD. Therapeutic effect of oral recombinant human granulocyte-macrophage colony-stimulating factor in radiotherapy-induced esophagitis[J]. Hepatogastroenterology ,2003,50(53): 1297
